SOTAC PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of SOTAC PHARMACEUTICALS have increased by 1.51% YoY .
The Earnings Per Share (EPS) of SOTAC PHARMACEUTICALS has decreased by -28.10 % YoY. |
||
SOTAC PHARMACEUTICALS Last 5 Annual Financial Results
[NSE : SOTAC]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹101 Cr | ₹100 Cr | ₹104 Cr | ₹77 Cr | ₹73 Cr |
| Expenses | ₹83 Cr | ₹83 Cr | ₹96 Cr | ₹70 Cr | ₹67 Cr |
| Operating Profit (Excl OI) | ₹18 Cr | ₹16 Cr | ₹8.32 Cr | ₹7.32 Cr | ₹6.17 Cr |
| Other Income | ₹0.35 Cr | ₹1.15 Cr | ₹0.49 Cr | ₹0.35 Cr | ₹0.22 Cr |
| Interest | ₹4.13 Cr | ₹2.58 Cr | ₹1.74 Cr | ₹2.04 Cr | ₹0.57 Cr |
| Depreciation | ₹5.41 Cr | ₹3.84 Cr | ₹3.10 Cr | ₹2.28 Cr | ₹1.13 Cr |
| Profit Before Tax | ₹8.70 Cr | ₹11 Cr | ₹3.96 Cr | ₹3.93 Cr | ₹4.70 Cr |
| Profit After Tax | ₹6.29 Cr | ₹9.28 Cr | ₹3.58 Cr | ₹2.29 Cr | ₹2.88 Cr |
| Consolidated Net Profit | ₹5.77 Cr | ₹8.03 Cr | ₹4.28 Cr | ₹2.88 Cr | ₹2.88 Cr |
| Earnings Per Share (Rs) | ₹5.22 | ₹7.26 | ₹3.87 | ₹3.58 | ₹12.52 |
| PAT Margin (%) | 6.22 | 9.30 | 3.45 | 2.95 | 3.94 |
| ROE(%) | 11.23 | 18.83 | 12.96 | 27.53 | 63.16 |
| ROCE(%) | 13.26 | 16.40 | 10.22 | 21.50 | 31.31 |
| Total Debt/Equity(x) | 0.64 | 0.82 | 0.55 | 2.21 | 1.12 |
Key Financials |
||
| Market Cap | : | ₹ 144.3 Cr |
| Revenue (TTM) | : | ₹ 95.6 Cr |
| Net Profit(TTM) | : | ₹ 3.8 Cr |
| EPS (TTM) | : | ₹ 3.4 |
| P/E (TTM) | : | 38.2 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SOTAC PHARMACEUTICALS | 16.4% | 23.3% | -18.7% |
| SUN PHARMACEUTICAL INDUSTRIES | 5.2% | 4.3% | 8% |
| DIVIS LABORATORIES | 3.6% | 7.6% | 50.5% |
| TORRENT PHARMACEUTICALS | 3.4% | 0.7% | 32.6% |
| CIPLA | 2% | 6% | -6.7% |
| DR REDDYS LABORATORIES | 2.3% | 14% | 13.6% |
| MANKIND PHARMA | 2.7% | 1.8% | 5.6% |
| LUPIN | -0.3% | -0.9% | 1.2% |
| ZYDUS LIFESCIENCES | -3.6% | 3.6% | 22.8% |
SOTAC PHARMACEUTICALS Revenues
[NSE : SOTAC]
| Y-o-Y | 1.51 % |
| 5 Yr CAGR | 8.46 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹101 Cr | 1.51 | |
| Mar2025 | ₹100 Cr | -3.94 | |
| Mar2024 | ₹104 Cr | 34.00 | |
| Mar2023 | ₹77 Cr | 5.92 | |
| Mar2022 | ₹73 Cr | - | |
SOTAC PHARMACEUTICALS Operating Profit
[NSE : SOTAC]
| Y-o-Y | 9.15 % |
| 5 Yr CAGR | 30.47 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹18 Cr | 9.15 | |
| Mar2025 | ₹16 Cr | 97.05 | |
| Mar2024 | ₹8.32 Cr | 13.67 | |
| Mar2023 | ₹7.32 Cr | 18.52 | |
| Mar2022 | ₹6.17 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 7.55 % |
| 5 Yr CAGR | 20.29 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 17.67% | 7.55 | |
| Mar2025 | 16.43% | 105.12 | |
| Mar2024 | 8.01% | -15.15 | |
| Mar2023 | 9.44% | 11.85 | |
| Mar2022 | 8.44% | - | |
SOTAC PHARMACEUTICALS Profit After Tax
[NSE : SOTAC]
| Y-o-Y | -28.15 % |
| 5 Yr CAGR | 18.97 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.77 Cr | -28.15 | |
| Mar2025 | ₹8.03 Cr | 87.50 | |
| Mar2024 | ₹4.28 Cr | 48.65 | |
| Mar2023 | ₹2.88 Cr | 0.03 | |
| Mar2022 | ₹2.88 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -33.12 % |
| 5 Yr CAGR | 12.09 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 6.22 % | -33.12 | |
| Mar2025 | 9.3 % | 169.57 | |
| Mar2024 | 3.45 % | 16.95 | |
| Mar2023 | 2.95 % | -25.13 | |
| Mar2022 | 3.94 % | - | |
SOTAC PHARMACEUTICALS Earnings Per Share (EPS)
[NSE : SOTAC]
| Y-o-Y | -28.10 % |
| 5 Yr CAGR | -19.64 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.22 | -28.10 | |
| Mar2025 | ₹7.26 | 87.60 | |
| Mar2024 | ₹3.87 | 8.10 | |
| Mar2023 | ₹3.58 | -71.41 | |
| Mar2022 | ₹13 | - | |
SOTAC PHARMACEUTICALS Return on Capital Employed (ROCE)
[NSE : SOTAC]
| Y-o-Y | -19.15 % |
| 5 Yr CAGR | -19.33 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 13.26% | -19.15 | |
| Mar2025 | 16.4% | 60.47 | |
| Mar2024 | 10.22% | -52.47 | |
| Mar2023 | 21.5% | -31.33 | |
| Mar2022 | 31.31% | - | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹130.0 |
| Current MarketCap | : | ₹ 144.3 Cr |
| Updated EOD on | : | Nov 05,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | 16.4% |
23.3% |
-18.7% |
| SENSEX | 8.8% |
10.9% |
-4% |
SOTAC PHARMACEUTICALS related INDICES
You may also like the below Video Courses
FAQ about SOTAC PHARMACEUTICALS Financials
How the annual revenues of SOTAC PHARMACEUTICALS have changed ?
The Revenues of SOTAC PHARMACEUTICALS have increased by 1.51% YoY .
How the Earnings per Share (EPS) of SOTAC PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of SOTAC PHARMACEUTICALS has decreased by -28.10 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs